Mydecine Patent Filing Links Psychedelic Therapeutics & PTSD: Psychedelic Stock Investing Oct 7, 2021
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded Smoking Cessation Study Lead by Dr.… Oct 5, 2021
Changing The Public’s View On Psychedelic Therapeutics With Mydecine Innovation’s Dr. Jetly Oct 1, 2021
Psilocybin For Substance Use: New U.S. Gov’t Funded Study On The Way, Plus 4 PubCo’s Studying It Sep 24, 2021
